Search

everythinglearnresearchcommunity

for

Search:↓

Future work on macrolide antibiotic analysis will aim to enhance selectivity, sensitivity, and efficiency using advanced chromatographic methods.

The Drug Ontology was updated to better classify drugs for hypertension, malaria, and opioid abuse, and to allow for more accurate research queries.

Eyelash alopecia areata often goes undiagnosed and can lead to complete eyelash regrowth, especially in younger patients.

Certain drugs are effective for skin conditions like psoriasis, vitiligo, and hair loss.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

PGF_2α receptors in human eyelids are found in specific parts of hair follicles, explaining eyelash changes with glaucoma treatment.

Hair loss in children is diagnosed and treated differently than in adults, with different common causes and a focus on less invasive methods.

The document concludes that validated methods are needed to ensure the quality of fluconazole drugs and that new antifungal medications are necessary due to safety and resistance concerns.

Hyaluronic acid fillers and combination treatments significantly improve facial defects from autoimmune diseases and are well-tolerated.

The review shows how to properly diagnose and treat the loss of eyebrow and eyelash hair.

The document concludes that early diagnosis and a comprehensive treatment plan are crucial for managing hair loss in children, with a focus on both medical and psychological support.

Topical bimatoprost 0.01% improves eyebrow density and diameter, especially at the tail.

Various treatments exist for alopecia areata, but none are completely satisfactory; choice depends on age, disease extent, and preference.

New treatments for vitiligo may focus on protecting melanocyte stem cells from stress and targeting specific pathways involved in the condition.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

Bimatoprost 0.03% is as effective as minoxidil 2% for eyebrow growth.

Many treatments for hair loss show potential, but more testing is needed to confirm their effectiveness. Only minoxidil for women and minoxidil and finasteride for men are FDA approved.

Some drugs have gained approval for new uses, while others like tricyclic antidepressants and aspirin show promise but aren't yet approved for these uses.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

The document concludes that identifying the cause of eyebrow and eyelash loss is key to treating it and improving quality of life.

The document explains various skin conditions and their treatments.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

Some chemicals can permanently or temporarily remove color from skin and hair, which can be distressing and is not well-regulated in cosmetics.

A woman with severe hair loss due to systemic sclerosis regrew her hair in 4 months using a combination of treatments.

Bimatoprost is effective for growing longer, thicker, and darker eyelashes.

Latisse (bimatoprost 0.03%) is widely used in dermatology but the document doesn't give detailed evidence or numbers.

Bimatoprost can help grow eyebrow hair.

There is not enough evidence to know if different ways of putting in eye drops for glaucoma work better than others.

Methotrexate effectively controls eye inflammation in Japanese patients with non-infectious uveitis but requires careful monitoring for side effects.